Table of Content

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in the Prevalence of Chronic Diseases
4.2.2 Increasing Adoption in Home Healthcare settings
4.2.3 Increasing Healthcare Investments in Developing Countries
4.3 Market Restraints
4.3.1 High Cost of Intravenous Infusion Pumps
4.3.2 Safety Issues and Stringent Regualtions
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Volumetric Pumps
5.1.2 Syringe Pumps
5.1.3 Patient-Controlled Analgesia Pump
5.2 By Application
5.2.1 Analgesia/Pain Management
5.2.2 Oncology
5.2.3 Parenteral Nutrition
5.2.4 Other Applications
5.3 By End-User
5.3.1 Hospitals
5.3.2 Home Healthcare
5.3.3 Other End-Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 B. Braun Melsungen AG
6.1.2 Baxter International Inc
6.1.3 Becton, Dickinson and Company
6.1.4 ICU Medical, Inc.
6.1.5 IRadimed Corporation
6.1.6 Mindray
6.1.7 Moog Inc.
6.1.8 Smiths Medical
6.1.9 Terumo Corporation
6.1.10 Zyno Medical


7 MARKET OPPORTUNITIES AND FUTURE TRENDS